Clinical Trials Logo

Clinical Trial Summary

The purpose of this project is to improve the clinical response and personal recovery of patients with treatment-resistant schizophrenia (TRS).


Clinical Trial Description

The Project aims to improve the efficacy of the first worldwide study of Deep Brain Stimulation (DBS) carried out in our hospital -PI12 / 00042: Deep Brain Stimulation in the treatment of refractory schizophrenia- through the implementation of a white matter tractography approach, which have demonstrated to improve efficacy in other DBS studies . Moreover, and in line with the National Strategy of Mental Health of the National Health System, this project aims to promote integrated and comprehensive care for patients with mental illness by multidisciplinary teams which includes family care, as we consider it is important to add to the DBS treatment program, a psychological intervention module based on the recovery model. Therefore, the main objectives of the present project are: i) to optimizethe efficacy and tolerability of DBS in TRS; ii) investigate whether the REFOCUS intervention improves the recovery of patients who are being treated with DBS. To this end, a double-blind, randomized, crossover clinical trial of DBS will be performed for 6 patients with TRS. Patients will be randomized to receive tractography-based target guidance DBS in the anterior cingulate cortex (ACC) or the nucleus accumbens (Nac). The 21 patient previously intervened with DBS (Affective disorders and TRS) and the ones included in this project, will enter into a psychological intervention phase, based on the REFOCUS model ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05337904
Study type Interventional
Source Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Contact Sandra Roldan, PhD
Phone +34 93 553 78 40
Email ARoldanB@santpau.cat
Status Recruiting
Phase N/A
Start date January 1, 2021
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03795935 - Relief From Side Effects: Clinical Use of Electrodes With Direction N/A
Recruiting NCT05493722 - Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy Early Phase 1
Recruiting NCT03221023 - Intrawound Vancomycin Prophylaxis for Neural Stimulator Phase 2/Phase 3
Recruiting NCT05968976 - Multicentre RCT of Awake Versus Asleep Tractography Based DBS for ET N/A
Recruiting NCT05417555 - Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease N/A
Recruiting NCT05022147 - Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease Phase 1
Recruiting NCT06078397 - Remote Programming for Deep Brain Stimulation in Parkinson's Disease. N/A
Recruiting NCT05065151 - Understanding Motivation in Parkinson's Patients Through Neurophysiology N/A
Completed NCT02947841 - The Effectiveness of Alternating Stimulation in Preventing Tolerance in Essential Tremor Patients N/A
Recruiting NCT05774041 - Visualization of the STN and GPi for DBS
Recruiting NCT06112067 - Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders N/A
Recruiting NCT05550714 - Choice of Anesthesia in Microelectrode Recording Guided Deep Brain Stimulation for Parkinson's Disease N/A
Completed NCT03696420 - Probabilistic Targeting of the VIM
Not yet recruiting NCT06121947 - Safety and Efficacy Study of Implantable Neuromodulation for Poststroke Hemiplegia N/A
Active, not recruiting NCT03347084 - Deep Brain Stimulation With LIFUP for Mild Cognitive Impairment and Mild Alzheimer's Disease N/A
Recruiting NCT05097001 - Dystonia Image-based Programming of Stimulation: A Prospective, Randomized, Double-blind Crossover Trial N/A
Recruiting NCT05905198 - Programming Strategy of VFS for Gait Impairments in PD N/A
Recruiting NCT02982512 - Dexmedetomidine on Basal Ganglia Neuronal Activity in Parkinson's Disease Phase 4
Recruiting NCT05568199 - Udall Project 1 Aim 4
Active, not recruiting NCT04530942 - The Efficacy and Prediction of Deep Brain Stimulation for Treatment-resistant Depression N/A